Parb Bioceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 3 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
About Parb Bioceuticals
Parb Bioceuticals Private Limited (PBPL) is a Private Limited Indian Non-Government Company incorporated in India on 11 May 2021 (Three years and eight months 27 days old ). Its registered office is in Sirmaur, Himachal Pradesh, India.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Konic Goyal, Parshotam Goyal, and Anuj Kumar serve as directors at the Company.
Company Details
-
Location
Sirmaur, Himachal Pradesh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24230HP2021PTC008554
-
Company No.
008554
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
11 May 2021
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Himachal Pradesh
Industry
Who are the key members and board of directors at Parb Bioceuticals?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Konic Goyal
|
Director | 11-May-2021 | Current |
|
Parshotam Goyal
|
Director | 11-May-2021 | Current |
|
Anuj Kumar
|
Additional Director | 20-May-2022 | Current |
Financial Performance of Parb Bioceuticals.
Enhance accessibility to Parb Bioceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Parb Bioceuticals?
Unlock access to Parb Bioceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Vellinton Healthcare Private LimitedKonic Goyal and Parshotam Goyal are mutual person
-
Ambrosia Drugs Private LimitedAnuj Kumar is a mutual person
-
Skincare Fiber Private LimitedKonic Goyal and Parshotam Goyal are mutual person
-
Parb Pharmaceuticals Private Limited
Konic Goyal and Anuj Kumar are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Parb Bioceuticals?
Unlock and access historical data on people associated with Parb Bioceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Parb Bioceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Parb Bioceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.